I Lauder

6.9k total citations
171 papers, 5.4k citations indexed

About

I Lauder is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, I Lauder has authored 171 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Pathology and Forensic Medicine and 21 papers in Oncology. Recurrent topics in I Lauder's work include Lymphoma Diagnosis and Treatment (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Viral-associated cancers and disorders (10 papers). I Lauder is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Viral-associated cancers and disorders (10 papers). I Lauder collaborates with scholars based in United Kingdom, Hong Kong and China. I Lauder's co-authors include James H. Pringle, Cyrus R. Kumana, Msm Ip, Ching‐Lung Lai, Bing Lam, W. Aherne, Cindy Lo Kuen Lam, Bernard M.Y. Cheung, Anthony Warford and Clara Ooi and has published in prestigious journals such as The Lancet, Gastroenterology and Journal of Molecular Biology.

In The Last Decade

I Lauder

168 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Lauder United Kingdom 40 1.2k 807 769 707 685 171 5.4k
Gary M. Brittenham United States 57 1.1k 0.9× 1.1k 1.4× 528 0.7× 1.2k 1.6× 426 0.6× 216 13.0k
Mark H. Wener United States 50 1.6k 1.3× 1.1k 1.3× 920 1.2× 1.4k 2.0× 1.2k 1.8× 153 9.0k
John F. Randolph United States 52 664 0.6× 513 0.6× 605 0.8× 771 1.1× 667 1.0× 261 9.7k
Brad H. Pollock United States 46 822 0.7× 746 0.9× 1.1k 1.4× 1.2k 1.7× 1.5k 2.2× 213 8.5k
John M. Weiner United States 40 1.1k 0.9× 1.5k 1.9× 921 1.2× 477 0.7× 687 1.0× 170 6.7k
John D. Mathews Australia 46 1.5k 1.3× 732 0.9× 907 1.2× 742 1.0× 311 0.5× 202 8.6k
Francisco Gudé Spain 41 875 0.7× 1.2k 1.5× 854 1.1× 606 0.9× 329 0.5× 246 6.5k
Chi Kong Li Hong Kong 48 1.2k 1.1× 737 0.9× 1.2k 1.6× 1.3k 1.8× 1.2k 1.8× 481 9.7k
Cheng‐Chieh Lin Taiwan 54 1.7k 1.4× 1.7k 2.1× 1.1k 1.4× 2.9k 4.1× 1.3k 2.0× 568 12.5k
Luca Chiovato Italy 59 1.3k 1.1× 848 1.1× 452 0.6× 2.4k 3.3× 935 1.4× 333 13.8k

Countries citing papers authored by I Lauder

Since Specialization
Citations

This map shows the geographic impact of I Lauder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Lauder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Lauder more than expected).

Fields of papers citing papers by I Lauder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Lauder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Lauder. The network helps show where I Lauder may publish in the future.

Co-authorship network of co-authors of I Lauder

This figure shows the co-authorship network connecting the top 25 collaborators of I Lauder. A scholar is included among the top collaborators of I Lauder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Lauder. I Lauder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumana, Cyrus R., et al.. (2005). Rhythm vs. rate control of atrial fibrillation meta‐analysed by number needed to treat. British Journal of Clinical Pharmacology. 60(4). 347–354. 23 indexed citations
2.
McGhee, SM, et al.. (2001). Cost-effectiveness analysis of applying the Cholesterol and Recurrent Events (CARE) study protocol in Hong Kong.. PubMed. 7(4). 360–8. 8 indexed citations
3.
Lam, Tai-Pong, et al.. (1998). Community attitudes toward living arrangements between the elderly and their adult children in Hong Kong. Journal of Cross-Cultural Gerontology. 13(3). 215–228. 18 indexed citations
4.
Siwak, Edward B., et al.. (1998). Selection of Appropriate HIV-1 Genomic Regions for Single-Strand Conformation Polymorphism Analysis of the Diversity, Modification, and Transmission of HIV-1 Quasispecies. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 18(5). 409–416. 4 indexed citations
5.
Kumana, Cyrus R., et al.. (1998). Bronchodilator Responses to Salbutamol Using Diskhaler Versus Metered-Dose Inhaler. Journal of Asthma. 35(6). 505–511. 9 indexed citations
6.
Cheng, Ignatius K.P., Karen S.L. Lam, Edward Janus, Richard Pang, & I Lauder. (1997). Treatment of Hyperlipidaemia in Patients with Non-Insulin-Dependent Diabetes mellitus with Progressive Nephropathy. Contributions to nephrology. 120. 79–87. 12 indexed citations
7.
Pang, Richard, et al.. (1996). Apolipoprotein (a) levels and phenotypes in NIDDM patients with microalbuminuria and albuminuria. Nephrology Dialysis Transplantation. 11(11). 2229–2236. 4 indexed citations
8.
Plank, Lukáš, et al.. (1995). ReactiveVersusNeoplastic Monocytoid B-Cell Proliferations:In Situ Hybridization Study of Immunoglobulin Light Chain mRNA. American Journal of Clinical Pathology. 103(3). 330–337. 11 indexed citations
9.
Lam, Cindy Lo Kuen, et al.. (1995). A pill for every ill?. Family Practice. 12(2). 171–175. 16 indexed citations
10.
Rutty, Guy N. & I Lauder. (1994). Mesothelial cell inclusions within mediastinal lymph nodes. Histopathology. 25(5). 483–487. 22 indexed citations
11.
Angel, C A, et al.. (1992). Vimentin expression by reed-Sternberg cells in Hodgkin's disease. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 421(1). 9–11. 4 indexed citations
12.
Angel, C A, et al.. (1991). Epstein–Barr viral DNA in Hodgkin's disease: Amplification and detection using the polymerase chain reaction. The Journal of Pathology. 165(1). 11–15. 34 indexed citations
13.
Pringle, James H., et al.. (1991). Demonstration of insulin and glucagon mRNA in routinely fixed and processed pancreatic tissue by in‐situ hybridization. The Journal of Pathology. 165(2). 105–110. 27 indexed citations
14.
Pringle, James H., et al.. (1990). Demonstration of Epstein‐Barr viral DNA in formalin‐fixed, paraffin‐embedded samples of Hodgkin's disease. The Journal of Pathology. 161(3). 255–260. 42 indexed citations
15.
Close, Pauline, et al.. (1990). Zonal distribution of immunoglobulin‐synthesizing cells within the germinal centre: An in situ hybridization and immunohistochemical study. The Journal of Pathology. 162(3). 209–216. 16 indexed citations
16.
West, K., et al.. (1989). A retrospective study of follicular lymphomas. Histopathology. 14(6). 629–636. 3 indexed citations
17.
Cartwright, R.A., P A McKinney, Claire O’Brien, et al.. (1988). Non-hodgkin's lymphoma: Case control epidemiological study in Yorkshire. Leukemia Research. 12(1). 81–88. 152 indexed citations
18.
Warford, Anthony, et al.. (1988). Southern blot analysis of DNA extracted from formol–saline fixed and paraffin wax embedded tissue. The Journal of Pathology. 154(4). 313–320. 39 indexed citations
19.
Angel, C A, Anthony Warford, Andrew Campbell, James H. Pringle, & I Lauder. (1987). The immunohistology of Hodgkin's disease—Reed–Sternberg cells and their variants. The Journal of Pathology. 153(1). 21–30. 40 indexed citations
20.
Buckton, K.E., M. S. NEWTON, I Lauder, et al.. (1975). Familial transmission of a (21q22q) translocation. Cytogenetic and Genome Research. 15(2). 103–111. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary M. Brittenham Breakdown of academic impact, for papers by Mark H. Wener Breakdown of academic impact, for papers by John F. Randolph Breakdown of academic impact, for papers by Brad H. Pollock Breakdown of academic impact, for papers by John M. Weiner Breakdown of academic impact, for papers by John D. Mathews Breakdown of academic impact, for papers by Francisco Gudé Breakdown of academic impact, for papers by Chi Kong Li Breakdown of academic impact, for papers by Cheng‐Chieh Lin Breakdown of academic impact, for papers by Luca Chiovato
Rankless by CCL
2026